Vaccine approaches conferring cross-protection against influenza viruses
نویسندگان
چکیده
منابع مشابه
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
Current influenza vaccines do not provide broad cross-protection. Here, we report that intranasal vaccination with virus-like particles containing the highly conserved multiple ectodomains of matrix protein 2 (M2e5x VLP) of influenza virus induces broad cross-protection by M2-specific humoral and cellular immune responses. M2e5x VLP intranasal vaccination prevented severe weight loss, attenuate...
متن کاملAdenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza
Few other diseases exert such a huge toll of suffering as influenza. We report here that intranasal (i.n.) administration of E1/E3-defective (ΔE1E3) adenovirus serotype 5 (Ad5) particles rapidly induced an anti-influenza state as a means of prophylactic therapy which persisted for several weeks in mice. By encoding an influenza virus (IFV) hemagglutinin (HA) HA1 domain, an Ad5-HA1 vector confer...
متن کاملLong‐term vaccine‐induced heterologous protection against H5N1 influenza viruses in the ferret model
BACKGROUND Highly pathogenic H5N1 influenza viruses reemerged in humans in 2003 and have caused fatal human infections in Asia and Africa as well as ongoing outbreaks in poultry. These viruses have evolved substantially and are now so antigenically varied that a single vaccine antigen may not protect against all circulating strains. Nevertheless, studies have shown that substantial cross-reacti...
متن کاملLive recombinant Salmonella oral vaccine against avian influenza viruses.
In 1997, the avian influenza virus (AIV) subtype H5N1 was first reported to infect humans.1 Up to 3 March 2015, the cumulative number of confirmed human cases of H5N1 was 784, with 429 deaths. There is no evidence that H5N1 viruses can transmit efficiently from person to person.2 Therefore, the key to prevention of a human H5N1 pandemic is to first control the H5N1 virus in birds. Traditionally...
متن کاملCross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model
BACKGROUND The virus-specific cytotoxic T lymphocyte (CTL) induction is an important target for the development of a broadly protective human influenza vaccine, since most CTL epitopes are found on internal viral proteins and relatively conserved. In this study, the possibility of developing a strain/subtype-independent human influenza vaccine was explored by taking a bioinformatics approach to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Vaccines
سال: 2017
ISSN: 1476-0584,1744-8395
DOI: 10.1080/14760584.2017.1379396